
Financial Analysis and Forecast of CVS Pharmacy, Inc.
- 1 Franklin & Marshall College, Lancaster, PA 17604, the United States
* Author to whom correspondence should be addressed.
Abstract
This article mainly discusses the general situation of CVS's operations, accounting analysis, performance valuation, and forecasting for the company's future. This article analyzes the three most significant sectors of CVS: pharmacy services, retail, and health care benefits. Some recent news shows a negative influence on CVS, including the coming Election and contaminated eye drops. This article discussed the impact of the news on the company. Moreover, this article explores the influence of inside events, including the acquisition of Oak Street Health. This article shows the potential risks and uncertain results caused by these events. The article talks about the clarity of the Accounting Analysis, mainly about Revenue recognition and Acquisitions and Assets Held for Sale. The article focuses on Key Data, Ratios, and Comparing with Competitors for performance valuation. Ultimately, the article uses different modules, including Free cash flow and enterprise value, to predict the future performance of the stock price. The article also lists the potential risks that the company will face in the future.
Keywords
CVS Pharmacy, Performance Evaluation, Accounting Analysis, Forecast
[1]. Kaye, A. D., Okeagu, C. N., Pham, A. D., Silva, R. A., Hurley, J. J., Arron, B. L., Sarfraz, N., Lee, H. N., Ghali, G., Gamble, J. W., Liu, H., Urman, R. D., & Cornett, E. M. (2021). Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Practice & Research Clinical Anaesthesiology, 35(3), 293–306.
[2]. Carlton, S., Lee, M., & Prakash, A. (2022). Insights into the 2022 individual health insurance market. McKinsey & Company. https://www.mckinsey.com/industries/healthcare/our-insights/insights-into-the-2022-individual-health-insurance-market
[3]. Carballo, R. (2023). Eyedrops from major brands may cause infection, F.D.A. says. The New York Times. https://www.nytimes.com/2023/10/29/us/eyedrops-fda-warning.html
[4]. Sainato, M. (2023). US pharmacy workers strike over ‘dangerous’ workloads as CVS and Walgreens rake in profits. The Guardian. https://www.theguardian.com/business/2023/oct/19/cvs-walgreens-strike-pharmacy-workers
[5]. Warburton, J. (2023). CVS is permanently closing hundreds of stores for a surprising reason. TheStreet. https://www.thestreet.com/retailers/cvs-is-permanently-closing-hundreds-of-stores-for-a-surprising-reason
[6]. Caylor, M. L. (2010). Strategic revenue recognition to achieve earnings benchmarks. Journal of Accounting and Public Policy, 29(1), 82–95.
[7]. Paugam, L., Astolfi, P., & Ramond, O. (2015). Accounting for business combinations: Do purchase price allocations matter? Journal of Accounting and Public Policy, 34(4), 362–391.
[8]. Pifer, R. (2023). CVS beats expectations in Q3, but high costs weigh on profit outlook. Healthcare Dive. https://www.healthcaredive.com/news/cvs-health-caremark-ma-utilization-q3-2023/698365/
[9]. Republicans abandon Obamacare repeal. (2022). NBC News. https://www.nbcnews.com/politics/congress/republicans-abandon-obamacare-repeal-rcna49538
[10]. Smith, J. (2023). Trimming the Retail: The investment outlook for CVS’s growth strategy. International Journal of Business & Economic Development, 11(02).
[11]. Guo, K. H., & Eschenbrenner, B. (2018). CVS Pharmacy: An instructional case of internal controls for regulatory compliance and IT risks. Journal of Accounting Education, 42, 17–26.
Cite this article
Guo,H. (2024). Financial Analysis and Forecast of CVS Pharmacy, Inc.. Advances in Economics, Management and Political Sciences,76,197-203.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 3rd International Conference on Business and Policy Studies
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).